» Articles » PMID: 39845097

Application Progress of Artificial Intelligence in Tumor Diagnosis and Treatment

Overview
Date 2025 Jan 23
PMID 39845097
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid advancement of artificial intelligence (AI) has introduced transformative opportunities in oncology, enhancing the precision and efficiency of tumor diagnosis and treatment. This review examines recent advancements in AI applications across tumor imaging diagnostics, pathological analysis, and treatment optimization, with a particular focus on breast cancer, lung cancer, and liver cancer. By synthesizing findings from peer-reviewed studies published over the past decade, this paper analyzes the role of AI in enhancing diagnostic accuracy, streamlining therapeutic decision-making, and personalizing treatment strategies. Additionally, this paper addresses challenges related to AI integration into clinical workflows and regulatory compliance. As AI continues to evolve, its applications in oncology promise further improvements in patient outcomes, though additional research is needed to address its limitations and ensure ethical and effective deployment.

References
1.
Pfob A, Heil J . Artificial intelligence to de-escalate loco-regional breast cancer treatment. Breast. 2023; 68:201-204. PMC: 9988657. DOI: 10.1016/j.breast.2023.02.009. View

2.
Xu H, Cha Y, Clemenceau J, Choi J, Lee S, Kang J . Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma. J Pathol Clin Res. 2022; 8(4):327-339. PMC: 9161341. DOI: 10.1002/cjp2.273. View

3.
Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, Schaefgen B, Kuemmel S . Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery. J Clin Oncol. 2022; 40(17):1903-1915. DOI: 10.1200/JCO.21.02439. View

4.
Kong J, Ha D, Lee J, Kim I, Park M, Im S . Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun. 2022; 13(1):3703. PMC: 9240063. DOI: 10.1038/s41467-022-31535-6. View

5.
Chen D, Liu J, Zang L, Xiao T, Zhang X, Li Z . Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients. Int J Biol Sci. 2022; 18(1):360-373. PMC: 8692161. DOI: 10.7150/ijbs.66913. View